WO1993013797B1 - Vaccin conjugue a base de toxine du cholera et de lypopolysaccharide (lps) detoxique, utilise pour la prevention du cholera - Google Patents
Vaccin conjugue a base de toxine du cholera et de lypopolysaccharide (lps) detoxique, utilise pour la prevention du choleraInfo
- Publication number
- WO1993013797B1 WO1993013797B1 PCT/US1993/000253 US9300253W WO9313797B1 WO 1993013797 B1 WO1993013797 B1 WO 1993013797B1 US 9300253 W US9300253 W US 9300253W WO 9313797 B1 WO9313797 B1 WO 9313797B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipopolysaccharide
- cholera
- vaccine
- detoxified
- protein carrier
- Prior art date
Links
- 229960005486 vaccines Drugs 0.000 title claims abstract 27
- 206010008631 Cholera Diseases 0.000 title claims 9
- 230000002265 prevention Effects 0.000 title claims 3
- 239000002596 immunotoxin Substances 0.000 title 1
- 241000607626 Vibrio cholerae Species 0.000 claims abstract 18
- 102000004965 antibodies Human genes 0.000 claims abstract 10
- 108090001123 antibodies Proteins 0.000 claims abstract 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract 9
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims abstract 8
- 102000009016 Cholera Toxin Human genes 0.000 claims abstract 5
- 108010049048 Cholera Toxin Proteins 0.000 claims abstract 5
- 229960005004 Cholera Vaccine Drugs 0.000 claims abstract 3
- 239000000203 mixture Substances 0.000 claims abstract 2
- 230000002850 vibriocidal Effects 0.000 claims abstract 2
- 239000002158 endotoxin Substances 0.000 claims 17
- 239000000969 carrier Substances 0.000 claims 14
- 125000002252 acyl group Chemical group 0.000 claims 4
- 230000001588 bifunctional Effects 0.000 claims 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 230000003053 immunization Effects 0.000 claims 4
- GZQKNULLWNGMCW-PWQABINMSA-J lipid A(4-) Chemical compound O1[C@H](CO)[C@@H](OP([O-])([O-])=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP([O-])([O-])=O)O1 GZQKNULLWNGMCW-PWQABINMSA-J 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 2
- XMSHRLOQLUNKSN-UHFFFAOYSA-N 4-(2,4-Dichlorobenzoyl)-1,3-dimethyl-5-hydroxypyrazole Chemical compound CC1=NN(C)C(O)=C1C(=O)C1=CC=C(Cl)C=C1Cl XMSHRLOQLUNKSN-UHFFFAOYSA-N 0.000 claims 2
- 206010013023 Diphtheria Diseases 0.000 claims 2
- 208000002672 Hepatitis B Diseases 0.000 claims 2
- 208000001877 Whooping Cough Diseases 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 150000008065 acid anhydrides Chemical class 0.000 claims 2
- 230000001580 bacterial Effects 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- 201000005702 pertussis Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000001681 protective Effects 0.000 claims 2
- 229960000814 tetanus toxoid Drugs 0.000 claims 2
- JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical group O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 claims 1
- IBVAQQYNSHJXBV-UHFFFAOYSA-N Adipic acid dihydrazide Chemical compound NNC(=O)CCCCC(=O)NN IBVAQQYNSHJXBV-UHFFFAOYSA-N 0.000 claims 1
- 231100000699 Bacterial toxin Toxicity 0.000 claims 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N Hexamethylenediamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 231100000765 Toxin Toxicity 0.000 claims 1
- 241000607598 Vibrio Species 0.000 claims 1
- 239000000688 bacterial toxin Substances 0.000 claims 1
- 230000001419 dependent Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 241000699802 Cricetulus griseus Species 0.000 abstract 1
- 238000005903 acid hydrolysis reaction Methods 0.000 abstract 1
- 230000000890 antigenic Effects 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 230000001413 cellular Effects 0.000 abstract 1
- 230000002346 endotoxic Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 239000002510 pyrogen Substances 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 230000002588 toxic Effects 0.000 abstract 1
Abstract
L'invention décrit une formulation de vaccin comprenant des conjugués composés de LPS détoxiqués et de protéines comprenant la toxine du choléra (CT). Le traitement à l'aide de l'hydrazine (DeA-LPS) réduit les caractéristiques endotoxiques du LPS à des niveaux admissibles, et produit une molécule plus importante, et à activité/antigénique accrue, par rapport au saccharide produit par hydrolyse acide. Des conjugués utilisant la toxine de V. cholerae sont également décrit, lesquels présentent de faibles niveaux de pyrogènes, aucune activité toxique par rapport aux cellules ovariennes du hamster chinois, et induisent des réponses de renforcement chez les anticorps vibriocides et les anticorps dirigés contre la toxine du choléra lorsqu'ils sont injectés par voie sous-cutanée sous forme de solutions salines dans des souris. Les conjuguées produits sous forme de vaccin contre le choléra induisent la formation des mêmes anticorps que les vaccins cellulaires à injection parentérale, mais présentent des caractéristiques immunologiques et une sécurité améliorées.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU34696/93A AU678549B2 (en) | 1992-01-16 | 1993-01-14 | Detoxified LPS-cholera toxin conjugate vaccine for prevention of cholera |
| JP5512624A JPH07503238A (ja) | 1992-01-16 | 1993-01-14 | コレラ予防用の無毒化ｌｐｓ−コレラ毒素結合ワクチン |
| EP93903428A EP0623026A1 (fr) | 1992-01-16 | 1993-01-14 | Vaccin conjugue a base de toxine du cholera et de lypopolysaccharide (lps) detoxique, utilise pour la prevention du cholera |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82145392A | 1992-01-16 | 1992-01-16 | |
| US07/821,453 | 1992-01-16 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| WO1993013797A2 WO1993013797A2 (fr) | 1993-07-22 |
| WO1993013797A3 WO1993013797A3 (fr) | 1993-10-28 |
| WO1993013797B1 true WO1993013797B1 (fr) | 1994-01-20 |
Family
ID=25233450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1993/000253 WO1993013797A2 (fr) | 1992-01-16 | 1993-01-14 | Vaccin conjugue a base de toxine du cholera et de lypopolysaccharide (lps) detoxique, utilise pour la prevention du cholera |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0623026A1 (fr) |
| JP (1) | JPH07503238A (fr) |
| AU (1) | AU678549B2 (fr) |
| CA (1) | CA2128212A1 (fr) |
| WO (1) | WO1993013797A2 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998026799A1 (fr) * | 1996-12-18 | 1998-06-25 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Vaccin conjugue contre la salmonella paratyphi a |
| US6531131B1 (en) | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
| AU2001253568A1 (en) | 2000-04-18 | 2001-10-30 | Dan C. Deborde | Lipopolysaccharide-conjugate vaccine for sepsis treatment |
| US7749511B2 (en) | 2000-04-18 | 2010-07-06 | Endobiologics, Incorporated | Anti-sepsis conjugate vaccine |
| US7527797B1 (en) | 2000-09-01 | 2009-05-05 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Vibrio cholerae 0139 conjugate vaccines |
| EP1372707A1 (fr) * | 2001-04-06 | 2004-01-02 | Institut Pasteur | Vaccin conjugue d'un fragment de polysaccharide de lipopolysaccharide du vibrio cholerae 0139 lie a l'anatoxine tetanique |
| AU2002309259A1 (en) * | 2002-05-09 | 2003-11-11 | Massimo Porro | Improved polysaccharide and glycoconjugate vaccines_____________ |
| EP1582217A1 (fr) * | 2002-11-14 | 2005-10-05 | Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros | Procede d'obtention de vaccins conjugues et de compositions vaccinales qui les contiennent. |
| US8048432B2 (en) | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| CN102824632A (zh) * | 2012-09-12 | 2012-12-19 | 北京民海生物科技有限公司 | 霍乱弧菌o1群多糖结合疫苗、其制备方法及应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2532850B1 (fr) * | 1982-09-15 | 1985-12-20 | Pasteur Institut | Conjugues immunogenes entre un haptene et une molecule porteuse derivee d'une toxine, les vaccins les composant et procede pour leur obtention |
| US4663160A (en) * | 1983-03-14 | 1987-05-05 | Miles Laboratories, Inc. | Vaccines for gram-negative bacteria |
-
1993
- 1993-01-14 WO PCT/US1993/000253 patent/WO1993013797A2/fr not_active Application Discontinuation
- 1993-01-14 CA CA002128212A patent/CA2128212A1/fr not_active Abandoned
- 1993-01-14 JP JP5512624A patent/JPH07503238A/ja active Pending
- 1993-01-14 EP EP93903428A patent/EP0623026A1/fr not_active Withdrawn
- 1993-01-14 AU AU34696/93A patent/AU678549B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2215933C (fr) | Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation | |
| EP0959905B1 (fr) | Conjugues de polysaccharide et de peptide | |
| EP0549617B1 (fr) | Vaccin ameliore | |
| Aplin et al. | Preparation, Properties, and Applications of Carbohydrate Conjugates of Proteins and Lipid | |
| US5433955A (en) | Site specific in vivo activation of therapeutic drugs | |
| Paoletti et al. | An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. | |
| JPS59175440A (ja) | グラム陰性バクテリアのワクチン | |
| WO2005072778A2 (fr) | Utilisation de groupes fonctionnels amino-oxy dans la preparation de vaccins | |
| EP1015027B1 (fr) | Procede de preparation de vaccins a base de conjugues comportant une proteine libre | |
| CA2253930A1 (fr) | Vaccins a base de conjugues proteine/polysaccharide prepares a l'aide de vinylsulfones homobifonctionnelles et heterobifonctionnelles | |
| US5849301A (en) | Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents | |
| WO1993013797B1 (fr) | Vaccin conjugue a base de toxine du cholera et de lypopolysaccharide (lps) detoxique, utilise pour la prevention du cholera | |
| EP0977588A2 (fr) | Couplage de proteines non modifiees a des polysaccharides derives d'haloacyle ou de dihaloacyle pour la preparation de vaccins renfermant des proteines-polysaccharides | |
| AU648015B2 (en) | Site specific in-vivo activation of therapeutic drugs | |
| Lee et al. | Neoglycoproteins as probes for binding and cellular uptake of glycoconjugates | |
| WO1993013797A3 (fr) | Vaccin conjugue a base de toxine du cholera et de lypopolysaccharide (lps) detoxique, utilise pour la prevention du cholera | |
| WO1996011709B1 (fr) | Synthese du vaccin antityphoidique a partir d'un polysaccharide de plante ou de fruit | |
| US4968495A (en) | Chemically modified bilirubin oxidase | |
| KR102493192B1 (ko) | 살모넬라 타이피 유래의 피막 다당류-단백질 접합체를 포함하는 백신 조성물 | |
| CA2338093A1 (fr) | Vaccins contre l'infection due a l'escherichia coli o157 | |
| NZ335984A (en) | Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents |